• Join
  • Login
  • Contact

Search abstracts

Information needs for pharmacists, patient advocates and patients to support adherence

  • In: G7 - HIV/AIDS: With improved access to medications, now what? Models to assure adherence and positive outcomes and associated information needs on Tuesday, 6 September 2005, 14:00-17:00
  • At: Cairo (Egypt) (2005)
  • Type: Presentation
  • By: SMITH, Gary (Univeristy of Maryland, Pharmacy Practice and Science, Baltimore, United States of America)
  • Abstract:

    Adherence in the context of patients with HIV/AIDS means the ability of patients to adhere to a regimen of highly active antiretroviral therapy (HAART) in order to achieve and maintain a non-detectable viral load and a CD4+ cell count above 200. Adherence is the most important factor in assuring successful outcomes with HAART. Studies have shown


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses